All Curated Mutation Sites in SARS-CoV-2

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Furin cleavage site

Methyltransferase

Non-coding region

Keyword: COVID-19-36672914

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	36672914	T478K	S	S	COVID-19	G C L	View
2	36672914	K417N	S	S	COVID-19	G C L	View
3	36672914	Y505H	S	S	COVID-19	I C L	View
4	36672914	T95A	S	S	COVID-19	C L	View
5	36672914	T547K	S	S	COVID-19	C L	View
6	36672914	S477N	S	S	COVID-19	I C L	View
7	36672914	S375F	S	S	COVID-19	C L	View
8	36672914	S373P	S	S	COVID-19	C L	View
9	36672914	S371L	S	S	COVID-19	C L	View
10	36672914	Q954H	S	S	COVID-19	C L	View
11	36672914	Q493R	S	S	COVID-19	I C L	View
12	36672914	P681H	S	S	COVID-19	I C L	View
13	36672914	N969K	S	S	COVID-19	C L	View
14	36672914	N856K	S	S	COVID-19	I C L	View
15	36672914	N764K	S	S	COVID-19	I C L	View
16	36672914	N679K	S	S	COVID-19	C L	View
17	36672914	N501Y	S	S	COVID-19	I C L	View
18	36672914	N440K	S	S	COVID-19	I C L	View
19	36672914	L981F	S	S	COVID-19	I C L	View
20	36672914	L212I	S	S	COVID-19	C L	View
21	36672914	H655Y	S	S	COVID-19	C L	View
22	36672914	G496S	S	S	COVID-19	I C L	View
23	36672914	G446S	S	S	COVID-19	I C L	View
24	36672914	G339D	S	S	COVID-19	C L	View
25	36672914	G142D	S	S	COVID-19	C L	View
26	36672914	E484A	S	S	COVID-19	I C L	View
27	36672914	D796Y	S	S	COVID-19	I C L	View
28	36672914	D614G	S	S	COVID-19	C L	View
29	36672914	A67V	S	S	COVID-19	C L	View
30	36672914	R203K	N	N	COVID-19	C L	View
31	36672914	P13L	N	N	COVID-19	C L	View
32	36672914	G204R	N	N	COVID-19	C L	View
33	36672914	Y234H	NSP6	ORF1a	COVID-19	C L	View
34	36672914	Q208R	NSP6	ORF1a	COVID-19	C L	View
35	36672914	I189V	NSP6	ORF1a	COVID-19	C L	View
36	36672914	P132H	NSP5	ORF1a	COVID-19	C L	View
37	36672914	T492I	NSP4	ORF1a	COVID-19	C L	View
38	36672914	L1266I	NSP3	ORF1a	COVID-19	C L	View
39	36672914	A1892T	NSP3	ORF1a	COVID-19	C L	View
40	36672914	P323L	NSP12	ORF1b	COVID-19	C L	View
41	36672914	F283S	NSP12	ORF1b	COVID-19	C L	View
42	36672914	Q19E	M	M	COVID-19	C L	View
43	36672914	D3G	M	M	COVID-19	C L	View
44	36672914	A63T	M	M	COVID-19	C L	View
45	36672914	T9I	E	E	COVID-19	C L	View
46	36672914	M87Y			COVID-19	C L	View
47	36672914	L260P			COVID-19	C L	View
48	36672914	K384R			COVID-19	C L	View
49	36672914	I42V			COVID-19	C L	View

Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.